{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:36:06Z","timestamp":1774485366227,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lungcan.2024.107918","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T06:11:53Z","timestamp":1722838313000},"page":"107918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma"],"prefix":"10.1016","volume":"195","author":[{"given":"Yiqun","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runmiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107918_b0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0272-5231(03)00061-3","article-title":"Pathology of lung cancer","volume":"23","author":"Travis","year":"2002","journal-title":"Clin. Chest Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Comprehen. Cancer Network"},{"issue":"suppl_4","key":"10.1016\/j.lungcan.2024.107918_b0025","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107918_b0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.lungcan.2024.107918_b0035","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/annonc\/mdt205","article-title":"Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)","volume":"24","author":"Dearden","year":"2013","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0040","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/annonc\/mdm003","article-title":"Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib","volume":"18","author":"Hirsch","year":"2007","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"issue":"10066","key":"10.1016\/j.lungcan.2024.107918_b0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0055","first-page":"223","article-title":"TIGD1 Is an independent prognostic factor that promotes the progression of colon cancer","volume":"39","author":"Zou","year":"2024","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.lungcan.2024.107918_b0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/1471-2164-10-498","article-title":"Inherent promoter bidirectionality facilitates maintenance of sequence integrity and transcription of parasitic DNA in mammalian genomes","volume":"10","author":"Kalitsis","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.lungcan.2024.107918_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.670129","article-title":"Prognostic and predictive value of transcription factors panel for digestive system carcinoma","volume":"11","author":"Fang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2024.107918_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2023.12.001","article-title":"Deregulated transcription factors in the emerging cancer hallmarks","volume":"98","author":"Hasan","year":"2024","journal-title":"Semin. Cancer Biol."},{"issue":"Pt 3","key":"10.1016\/j.lungcan.2024.107918_b0075","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.semcancer.2022.10.001","article-title":"Deregulated transcription factors in cancer cell metabolisms and reprogramming","volume":"86","author":"Kant","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","article-title":"Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention","volume":"33","author":"Kaufhold","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107918_b0085","doi-asserted-by":"crossref","first-page":"1374260","DOI":"10.3389\/fmed.2024.1374260","article-title":"Bioinformatics analysis and experimental verification of TIGD1 in non-small cell lung cancer","volume":"11","author":"Xia","year":"2024","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107918_b0090","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1002\/jcb.28256","article-title":"TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer","volume":"120","author":"Yin","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107918_b0095","first-page":"3424","article-title":"SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target","volume":"42","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif)."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107918_b0105","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","article-title":"MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins","volume":"290","author":"Park","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107918_b0110","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1093\/nar\/gky186","article-title":"A novel transcript isoform of STING that sequesters cGAMP and dominantly inhibits innate nucleic acid sensing","volume":"46","author":"Wang","year":"2018","journal-title":"Nucl. Acids Res."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107918_b0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucl. Acids Res."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107918_b0125","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucl. Acids Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0130","first-page":"523","article-title":"Causal analysis approaches in Ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics (Oxford, England)."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0135","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2024.107918_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.lungcan.2024.107918_b0145","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107918_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107918_b0160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107918_b0165","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mc.23557","article-title":"A novel oncogene trigger transposable element derived-1 promotes oral squamous cell carcinoma progression via evoking immune inhibition","volume":"62","author":"Qiao","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lungcan.2024.107918_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-319-24932-2_3","article-title":"Epithelial mesenchymal transition in aggressive lung cancers","volume":"890","author":"Mittal","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0175","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3892\/or.2016.4964","article-title":"The biological role of epithelial-mesenchymal transition in lung cancer (Review)","volume":"36","author":"Sung","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2024.107918_b0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1741-7015-6-14","article-title":"miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells","volume":"6","author":"Silber","year":"2008","journal-title":"BMC Med."},{"issue":"16","key":"10.1016\/j.lungcan.2024.107918_b0185","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1158\/0008-5472.CAN-10-0622","article-title":"Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis","volume":"70","author":"Balaguer","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13577-013-0085-4","article-title":"miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin","volume":"27","author":"Bi","year":"2014","journal-title":"Hum. Cell"},{"key":"10.1016\/j.lungcan.2024.107918_b0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijbiomac.2014.12.002","article-title":"microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18","volume":"74","author":"Zhang","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107918_b0200","first-page":"1876","article-title":"MicroRNA-137-regulated AKT serine\/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer","volume":"16","author":"Lu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0205","first-page":"511","article-title":"MiR-137 and its target TGFA modulate cell growth and tumorigenesis of non-small cell lung cancer","volume":"21","author":"Liu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107918_b0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0220","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1038\/s41467-021-25523-5","article-title":"Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity","volume":"12","author":"Adhikari","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107918_b0225","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5055","article-title":"Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL-6\/JAK\/STAT3 pathway in non-small cell lung cancer","volume":"48","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107918_b0230","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","article-title":"JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107918_b0235","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","article-title":"The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer","volume":"49","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2024.107918_b0240","article-title":"IL-6: the link between inflammation, immunity and breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107918_b0245","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Hong","year":"2007","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.lungcan.2024.107918_b0250","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.2174\/0929867324666170712160621","article-title":"Immunotherapeutic interleukin-6 or interleukin-6 receptor blockade in cancer: challenges and opportunities","volume":"25","author":"Kampan","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107918_b0255","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107918_b0260","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.7150\/ijbs.31999","article-title":"An autocrine IL-6\/IGF-1R loop mediates EMT and promotes tumor growth in non-small cell lung cancer","volume":"15","author":"Zheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12776","article-title":"IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-\u03baB","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"issue":"14","key":"10.1016\/j.lungcan.2024.107918_b0270","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in Hepatocellular Carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107918_b0275","doi-asserted-by":"crossref","first-page":"F310","DOI":"10.1152\/ajprenal.00428.2016","article-title":"IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2\/STAT3 signaling pathway","volume":"313","author":"Xiao","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107918_b0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2016.02.048","article-title":"Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement","volume":"375","author":"Bharti","year":"2016","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107918_b0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"issue":"24","key":"10.1016\/j.lungcan.2024.107918_b0290","doi-asserted-by":"crossref","first-page":"25189","DOI":"10.18632\/aging.104120","article-title":"Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging"},{"issue":"13","key":"10.1016\/j.lungcan.2024.107918_b0295","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","article-title":"CXCL1 Is critical for premetastatic niche formation and metastasis in colorectal cancer","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"issue":"630","key":"10.1016\/j.lungcan.2024.107918_b0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf5473","article-title":"CECR2 drives breast cancer metastasis by promoting NF-\u03baB signaling and macrophage-mediated immune suppression","volume":"14","author":"Zhang","year":"2022","journal-title":"Sci. Transl. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T01:30:48Z","timestamp":1725586248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224004525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":60,"alternative-id":["S0169500224004525"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107918","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107918"}}